Thanks TB & Hottod.
The link below shows Stoke have just been granted FDA Orphan Drug Designation (ANN on 27 august) and they are expecting to file an IND application in early 2020 and to begin phase 1/2 in the first half of 2020.
IMO PYC would file for this in the first half of 2020.
https://investor.stoketherapeutics.com/news-releases/news-release-details/stoke-therapeutics-granted-fda-orphan-drug-designation-stk-001
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
0.000(0.00%) |
Mkt cap ! $702.8M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.23 | $1.20 | $657.3K | 547.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 311000 | $1.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 11842 | 3 |
View Market Depth
| Last trade - 13.29pm 24/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |